Solutions · Pillar

Regenerative Medicine - Autologous Therapies

Autologous platelet-rich therapies, bone-marrow aspirate concentrate, and nanofat for tissue regeneration. All sourced from the patient - no donor or animal material.

Pillar Overview

OrganoGEN's Regenerative Medicine portfolio is fully autologous - every therapy is sourced from the patient's own blood, marrow, or adipose tissue. Vivostat® autologous fibrin sealant (Denmark), Endoret® PRGF Plasma Rich in Growth Factors (BTI, Spain - 500+ peer-reviewed publications across 25+ years), Marrow Cellution™ BMAC harvest (Aspire, USA), and Tulip® Nanofat adipose grafting (Tulip, USA - OrganoGEN is the Cyprus-exclusive distributor) cover orthopaedic, sports-medicine, and aesthetic indications. In Cyprus, regenerative therapies sit in the private-pay tier, outside GESY reimbursement.

Conditions treated

Talk to OrganoGEN about Regenerative Medicine

Surgeons, hospitals, and patients: reach the right product, procedure, or clinic in one call.

Get in touch
mail_outlineGET IN TOUCH
arrow_back
Regenerative Medicine
Regenerative Medicine · Cyprus

Regenerative Medicine - Autologous Therapies

Autologous platelet-rich therapies, bone-marrow aspirate concentrate, and nanofat for tissue regeneration. Private-pay in Cyprus, outside GESY.

Products

Implants & devices

Procedures

Procedure guides

Conditions Treated

What we help with